{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Initiating Pre-exposure Prophylaxis: What Primary Care Providers Should Know

Activity Steps

Learning Objectives

After completing this continuing education activity you will be able to:

  1. Identify risk factors for new HIV infections and candidate considerations for pre-exposure prophylaxis (PrEP).
  2. Describe available PrEP medications including available combinations, administration, and common adverse reactions.
  3. Explain follow-up testing, counseling, and patient education for patients on PrEP.

Learning Outcomes

By completing this activity and taking the posttest, participants will achieve a minimum score of 70%.
Price: $21.95

Credits:

  • ANCC 2.0 CH / 2.0 APH
  • DC - BON 2.0 CH
  • FL - BON 2.0 CH
  • GA - BON 2.0 CH

Lippincott Professional Development is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation. This activity is also provider approved by the California Board of Registered Nursing, Provider Number CEP 11749. Lippincott Professional Development is also an approved provider of continuing nursing education by the District of Columbia Board of Nursing, Florida Board of Nursing, Georgia Board of Nursing, New Mexico Board of Nursing, South Carolina Board of Nursing, and West Virginia Board of Examiners for Registered Professional Nurses, #50-1223.

Awarded Advanced Pharmacology Hours







Test Code: NP0821A
Published: Aug 2021
Expires: 6/7/2024
Required Passing Score: 8/10 (80%)
Authors: Yeow Chye Ng, PhD; FNP-BC, NP-C, CPC, FAANP; Jack J. Mayeux, DNP, FNP-C